Although our studysuggests that H19 could be accounted for a potential therapeutic target oruseful predictive biomarker in ALL patients, further investigation is needed to identify themolecular mechanisms underlying H19 function in pathological process and/orcarcinogenesis in this disease. The gene discussed is H19; the disease is acute lymphoblastic leukemia.